Clinical Trials Browser

Tertiary Lymphoid Structures, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Sarcoma, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT06555263 2025-08-22

Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer

Phase 2 Withdrawn

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04615884 2025-07-28

CH:II

Phase NA Withdrawn

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT05879484 2025-07-10

Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS

Phase 1/2 Withdrawn

Head & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lung Neoplasms

NCT04214015 2025-06-05

A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma

Withdrawn

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT06494046 2025-06-04

Defining Musical Toxicity and Its Effect on Patient Well-being

Withdrawn

BreastCNSGastrointestinalThoracic

Brain Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms

NCT05840770 2025-05-26

Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer

Phase 2 Withdrawn

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03877250 2025-05-15

Analysis of Biopsy Specimens to Study Responses to PD-1 or PD-L1 Therapies

Withdrawn

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06522360 2025-04-24

Brigatinib Plus Chemotherapy or Local Consolidation Therapy in ALK Positive Advanced Non-small Cell Lung Cancer (BrightStar-2)

Phase 2 Withdrawn

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04485026 2025-04-17

Local Consolidative Radiotherapy for Oligoprogressive in Non-small Cell Lung Carcinoma

Phase 2 Withdrawn

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05358691 2025-04-16

A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants

Phase 1 Withdrawn

Thoracic

Lung Neoplasms

NCT05648188 2025-04-10

LUNGadenosine

Withdrawn

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06895941 2025-04-08

Predictive Value of PET/CT for Efficacy of Neoadjuvant Immunotherapy in Non-small Cell Lung Cancer

Withdrawn

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Clinical Trials

Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma

Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting

CheckCell-2

ARTIA-Lung

EPIC

Neo-Kan

AI-Lung

BIB 01

EMPIRE

Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer

CH:II

Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS

A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma

Defining Musical Toxicity and Its Effect on Patient Well-being

Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer

Analysis of Biopsy Specimens to Study Responses to PD-1 or PD-L1 Therapies

Brigatinib Plus Chemotherapy or Local Consolidation Therapy in ALK Positive Advanced Non-small Cell Lung Cancer (BrightStar-2)

Local Consolidative Radiotherapy for Oligoprogressive in Non-small Cell Lung Carcinoma

A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants

LUNGadenosine

Predictive Value of PET/CT for Efficacy of Neoadjuvant Immunotherapy in Non-small Cell Lung Cancer